Esketamine nasal spray combined with an oral antidepressant for relapse prevention in treatment-resistant depression: results of a double-blind, randomized withdrawal, multicenter study (sustain-1)
| Autor: | Daly, E.J., Trivedi, M., Janik, A., Li, H., Zhang, Y., Li, X., Lane, R., Duca, A.R., Hough, D., Thase, M.E., Zajecka, J., Winokur, A., Divacka, I., Fagiolini, A., Cubala, W.J., Bitter, I., Blier, P., Shelton, R.C., Molero, P., Manji, H., Drevets, W.C., Singh, J.B. |
|---|---|
| Zdroj: | In European Neuropsychopharmacology 2019 29 Supplement 1:S92-S92 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect